Cost-Effectiveness Analysis of Intravitreal Aflibercept for the Prevention of Progressive Diabetic Retinopathy

June 2022 Written by:  Wenlan Zhang, MD Retina Northwest Portland, OR Patel, N. Yannuzzi, N. Lin, J. Smiddy, W. A Cost-Effectiveness Analysis of Intravitreal Aflibercept for the Prevention of Progressive Diabetic Retinopathy. Ophthalmol Retina. 2022;6:213-218. This was a cost-effectiveness analysis based on published data from two recent randomized control trials studying the early treatment of […]

Postoperative Endophthalmitis in Immediate Sequential Bilateral Cataract Surgery

May 2022 Written by: Phillip Storey, MD Austin Retina Associates Austin, TX Friling E, Johansson B, Londsteom M, et al. Postoperative endophthalmitis in immediate sequential bilateral cataract surgery: a nationwide registry study.Ophthalmology. 2022;129(1):26-34. Lacy M, Kung T, Owens J, et al. Endophthalmitis rate in immediately sequential versus delayed sequential bilateral cataract surgery within the IRIS registry […]

Faricimab and DME: YOSEMITE and RHINE (Phase 3 Trial)

May 2022 Written by: Edward Wood, MD Austin Retina Associates Austin, TX Wykoff, C. C., F. Abreu, A. P. Adamis, and K. Basu. 2022. “Efficacy, Durability, and Safety of Intravitreal Faricimab with Extended Dosing up to Every 16 Weeks in Patients with Diabetic Macular Oedema (YOSEMITE and RHINE): two randomized, double-masked, phase 3 trials. The Lancet. […]

Accuracy of Spectral-Domain OCT of the Macula for Detection of Complete Posterior Vitreous Detachment

May 2022 Written by: Daniel Su, MD Retina-Vitreous Associates Medical Group Los Angeles, CA Hwang ES, Kraker JA, Griffin KJ, Sebag J, Weinberg DV, Kim JE. Accuracy of Spectral-Domain OCT of the Macula for Detection of Complete Posterior Vitreous Detachment. Ophthalmol Retina. 2020 Feb;4(2):148-153.  Posterior vitreous detachment (PVD) is the age-related separation of vitreous from […]

Safety Outcomes of Brolucizumab in Neovascular Age-related Macular Degeneration: Results from the IRIS Registry and Komodo Healthcare Map

April 2022 Written by: Akshay Thomas, M.D. Tennessee Retina Nashville, TN Khanani AM, Zarbin MA, Barakat MR, et al. Safety outcomes of brolucizumab in neovascular age-related macular degeneration: results from the iris registry and komodo healthcare map. JAMA Ophthalmol. 2022;140(1):20-28. Treatment options for wet AMD include off-label use of bevacizumab or use of an FDA-approved […]

Vitrectomy for Symptomatic Asteroid Hyalosis

April 2022 Written by: Vlad Matei, M.D. Rocky Mountain Retina Associates Boulder, CO Marlow E, Hassan T, Faia L, et al. Vitrectomy for symptomatic asteroid hyalosis. J Vitreoretin Dis 2021;5(5):420-424. Asteroid hyalosis (AH) is a common and benign degeneration consisting of calcium- and lipid-rich opacities, termed asteroid bodies (ABs), accumulating in the vitreous gel. Until […]